摘要 |
The present disclosure provides methods for assessing a patient's cancer risk and/or recurrence risk, which methods comprise assaying, in a biological sample obtained from the gastrointestinal (GI) tract of the patient, an expression level of a risk gene. The present disclosure also provides methods involving a cancer risk/recurrence risk sequence, i.e. the V600E mutation of the BRAF gene, which is useful for assessing cancer risk and/or recurrence risk in a patient. |
申请人 |
GENOMIC HEALTH INC.;COWENS, WAYNE;CRONIN, MAUREEN T.;MILLWARD, CARL L.;COLLIN, FRANCOIS;CRAGER, MICHAEL |
发明人 |
COWENS, WAYNE;CRONIN, MAUREEN T.;MILLWARD, CARL L.;COLLIN, FRANCOIS;CRAGER, MICHAEL |